Beta Alethine in Treating Patients With Low-Grade Lymphoma
Status:
Unknown status
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
RATIONALE: Biological therapies such as beta alethine use different ways to stimulate the
immune system and stop cancer cells from growing.
PURPOSE: Phase I/II trial to study the effectiveness of beta alethine in treating patients
who have low-grade lymphoma.